{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreickbgcklq7lm47owvnfqcp2zk2so2wug424skuvmqpp4mu52svcom",
    "uri": "at://did:plc:tpd4fxsnyhzzhnj6g4llqsfn/app.bsky.feed.post/3mp272eymm4a2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiflq5xsj3yfy2cpuprkgpaabjam5uhnwpm36w7xfy5psrhhhm2laq"
    },
    "mimeType": "image/jpeg",
    "size": 21555
  },
  "path": "/news/11935696/drug-treats-sleep-apnea-adults-obesity-approved/",
  "publishedAt": "2026-06-24T13:39:23.000Z",
  "site": "https://globalnews.ca",
  "tags": [
    "Canada",
    "Health",
    "GLP-1 drugs",
    "Health Canada",
    "Obesity",
    "Sleep Apnea"
  ],
  "textContent": "Zepbound the now the only GLP-1 drug in Canada approved for the sleep disorder that causes people to stop breathing temporarily because their upper airway is blocked.",
  "title": "Health Canada approves drug that treats sleep apnea in adults with obesity"
}